As demand for rapid testing continues to accelerate at an unprecedented level, our response to assisting testing on a global scale must be in place to support accurate, reliable and easy-to-use testing. 

The AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC, achieves 98.03% sensitivity and 99.5% specifically, will play an invaluable role in overcoming unpredicted rapid testing outcomes.

Download the whitepaper to learn:

• How the body responds to SARS-COV-2
• The different approaches to antibody testing
• The UK-RTC Abc-19 Rapid Test
• The link between antibodies and immunity
• The route towards therapies and immunisation 

Please access the complete whitepaper for this device here.